Close

Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications

Go back to Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications
(NASDAQ: KRYS) Delayed: 169.91 +0.16 (0.09%)
Previous Close $169.75    52 Week High
Open $170.90    52 Week Low
Day High $172.44    P/E N/A 
Day Low $168.96    EPS
Volume 102,268